# Study of Erythromycin in GER-Associated Apnea of the Newborn

> **NCT01825473** · NA · UNKNOWN · sponsor: **University of Virginia** · enrollment: 40 (estimated)

## Conditions studied

- Gastroesophageal Reflux
- Apnea
- Bradycardia

## Interventions

- **DRUG:** Erythromycin
- **DEVICE:** Multi-channel intra-luminal impedance (MII) pH monitoring
- **DRUG:** Placebo (D5W)

## Key facts

- **NCT ID:** NCT01825473
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825473, "Study of Erythromycin in GER-Associated Apnea of the Newborn". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01825473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*